Correlation Between Fennec Pharmaceuticals and Quest PharmaTech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Fennec Pharmaceuticals and Quest PharmaTech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fennec Pharmaceuticals and Quest PharmaTech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fennec Pharmaceuticals and Quest PharmaTech, you can compare the effects of market volatilities on Fennec Pharmaceuticals and Quest PharmaTech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fennec Pharmaceuticals with a short position of Quest PharmaTech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fennec Pharmaceuticals and Quest PharmaTech.

Diversification Opportunities for Fennec Pharmaceuticals and Quest PharmaTech

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Fennec and Quest is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Fennec Pharmaceuticals and Quest PharmaTech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Quest PharmaTech and Fennec Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fennec Pharmaceuticals are associated (or correlated) with Quest PharmaTech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Quest PharmaTech has no effect on the direction of Fennec Pharmaceuticals i.e., Fennec Pharmaceuticals and Quest PharmaTech go up and down completely randomly.

Pair Corralation between Fennec Pharmaceuticals and Quest PharmaTech

Given the investment horizon of 90 days Fennec Pharmaceuticals is expected to generate 0.95 times more return on investment than Quest PharmaTech. However, Fennec Pharmaceuticals is 1.05 times less risky than Quest PharmaTech. It trades about -0.01 of its potential returns per unit of risk. Quest PharmaTech is currently generating about -0.07 per unit of risk. If you would invest  983.00  in Fennec Pharmaceuticals on September 14, 2024 and sell it today you would lose (367.00) from holding Fennec Pharmaceuticals or give up 37.33% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Fennec Pharmaceuticals  vs.  Quest PharmaTech

 Performance 
       Timeline  
Fennec Pharmaceuticals 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Fennec Pharmaceuticals are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating basic indicators, Fennec Pharmaceuticals exhibited solid returns over the last few months and may actually be approaching a breakup point.
Quest PharmaTech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Quest PharmaTech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical and fundamental indicators, Quest PharmaTech is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Fennec Pharmaceuticals and Quest PharmaTech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Fennec Pharmaceuticals and Quest PharmaTech

The main advantage of trading using opposite Fennec Pharmaceuticals and Quest PharmaTech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fennec Pharmaceuticals position performs unexpectedly, Quest PharmaTech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Quest PharmaTech will offset losses from the drop in Quest PharmaTech's long position.
The idea behind Fennec Pharmaceuticals and Quest PharmaTech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Complementary Tools

Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Stocks Directory
Find actively traded stocks across global markets